An unexpected role for anticoagulant heparan sulfate proteoglycans in reproduction

Swiss Medical Weekly

Volumn 136, Issue 37-38, 2006, Pages 583-590

  De Agostini, Ariane I ^a,b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b Fondation pour Recherches Médicales   (Switzerland)

Author keywords

Coagulation; Heparan sulfate; Ovulation; Reproduction; Serpin

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBIN III; GONADOTROPIN; HEPARIN; PROTEOHEPARAN SULFATE; SERINE PROTEINASE INHIBITOR;

AMINO ACID SEQUENCE; ENDOTHELIUM CELL; ENZYME ACTIVATION; FEMALE FERTILITY; FEMALE GENITAL SYSTEM; HUMAN; INFLAMMATION; INTRAUTERINE GROWTH RETARDATION; NONHUMAN; OVARY FUNCTION; OVULATION; PLACENTA DEVELOPMENT; PREECLAMPSIA; PREGNANCY; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; REPRODUCTION; REVIEW;

EID: 33749614591     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (61)

1. Shalgi R, Kraicer P, Rimon A, Pinto M, Soferman N. Proteins of human follicular fluid: the blood-follicle barrier. Fertil Steril 1973;24:429-34.
2. Ny T, Peng XR, Ohlsson M. Hormonal regulation of the fibrinolytic components in the ovary. Thromb Res 1993;71:1-45.
3. Tsafriri A, Reich R. Molecular aspects of mammalian ovulation. Exp Clin Endocrinol Diabetes 1999;107:1-11.
4. Kamat BR, Brown LF, Manseau EJ, Senger DR, Dvorak HF. Expression of vascular permeability factor/vascular endothelial growth factor by human granulosa and theca lutein cells. Role in corpus luteum development. Am J Pathol 1995;146:157-65.
5. Yanagishita M. Proteoglycans and hyaluronan in female reproductive organs. Experientia 1994;70:179-90.
6. Capila I, Linhardt RJ. Heparin-protein interactions. Angew Chem Int Ed Engl 2002;41:390-412.
7. Rosenberg RD, Shworak NW, Liu J, Schwartz JJ, Zhang L. Heparan sulfate proteoglycans of the cardiovascular system. Specific structures emerge but how is synthesis regulated? J Clin Invest 1997;99:2062-70.
8. Carrell R, Skinner R, Jin L, Abrahams JP. Structural mobility of antithrombin and its modulation by heparin. Thromb Haemost 1997;78:516-9.
9. Shworak NW, Liu J, Petros LM, Zhang L, Kobayashi M, Copeland NG, Jenkins NA, Rosenberg RD. Multiple Isoforms of Heparan Sulfate D-Ghicosaminyl 3-O-Sulfotransferase. Isolation, characterization, and expression of human cdnas and identification of distinct genomic loci. J Biol Chem 1999;274: 5170-84.
10. Ye S, Luo Y, Lu W, Jones RB, Linhardt RJ, Capila I, Toida T, Kan M, Pelletier H, McKeehan WL. Structural basis for interaction of FGF-1, FGF-2, and FGF-7 with different heparan sulfate motifs. Biochem 2001;40:14429-39.
11. Liu J, Shworak NW, Sinay P, Schwartz JJ, Zhang L, Fritze LM, Rosenberg RD. Expression of Heparan Sulfate D-Glucosaminyl 3-O-Sulfotransferase Isoforms Reveals Novel Substrate Specificities. J Biol Chem 1999;274:5185-92.
12. Xia G, Chen J, Tiwari V, Ju W, Li JP, Malmstrom A, Shukla D, Liu J. Heparan sulfate 3-O-sulfotransferase isoform 5 generates both an antithrombin-binding site and an entry receptor for herpes simplex virus, type 1. J Biol Chem 2002;277:37912-9.
13. Marcum JA, Atha DH, Fritze LMS, Nawroth P, Stern D, Rosenberg RD. Cloned bovine aortic endothelial cells synthesize anticoagulantly active heparan sulfate proteoglycan. J Biol Chem 1986;261:7507-17.
14. de Agostini AI, Watkins SC, Slayter HS, Youssoufian H, Rosenberg RD. Localization of anticoagulantly active heparan sulfate proteoglycans in vascular endothelium: antithrombin binding on cultured endothelial cells and perfused rat aorta. J Cell Biol 1990;111:1293-304.
15. Marcum JA, McKenny JB, Rosenberg RD. Acceleration of thrombin- antithrombin complex formation in rat hindquarters via heparinlike molecules bound to the endothelium. J Clin Invest 1984;74:341-50.
16. Xu Y, Slayter HS. Immunocytochemical localization of endogenous antithrombin III in the vasculature of rat tissues reveals locations of anticoagulantly active heparan sulfate proteoglycans. J Histochem Cytochem 1994;42:1365-76.
17. de Agostini AI, Ramus MA, Rosenberg RD. Differential partition of anticoagulant heparan sulfate proteoglycans synthesized by endothelial and fibroblastic cell lines. J Cell Biochem 1994; 54:174-85.
18. Pejler G, Backstrom G, Lindahl U, Paulsson M, Dziadek M, Fujiwara S, Timpl R. Structure and affinity for antithrombin of heparan sulfate chains derived form basement membrane proteoglycans. J Biol Chem 1987;262:5036-43.
19. Marcum JA, Conway EM, Youssoufian H, Rosenberg RD. Anticoagulantly active heparin-like molecules from cultured fibroblasts. Exp Cell Res 1986;166:253-8.
20. Andrade-Gordon P, Wang SY, Strickland S. Heparin-like activity in porcine follicular fluid and rat granulosa cells. Thromb Res 1992;66:475-87.
21. Hosseini G, Liu J, de Agostini A. Characterization and hormonal modulation of anticoagulant heparan sulfate proteoglycans synthesized by rat ovarian granulosa cells. J Biol Chem 1996;271:22090-9.
22. Princivalle M, Hasan S, Hosseini G, de Agostini AI. Anticoagulant heparan sulfate proteoglycans expression in the rat ovary peaks in preovulatory granulosa cells. Glycobiol 2001;11: 183-94.
23. Ishiguro K, Kojima T, Taguchi O, Saito H, Muramatsu T, Kadomatsu K. Syndecan-4 expression is associated with follicular atresia in mouse ovary. Histochem Cell Biol 1999;112:25-33.
24. Murdoch AD, Liu B, Schwarting R, Tuan RS, Iozzo RV. Wide-spread expression of perlecan proteoglycan in basement membranes and extracellular matrices of human tissues as detected by a novel monoclonal antibody against domain III and by in situ hybridization. J Histochem Cytochem 1994;42:239-49.
25. Eriksen GV, Carlstedt I, Morgelin M, Uldbjerg N, Malmstrom A. Isolation and characterization of proteoglycans from human follicular fluid. Biochem J 1999;340:613-20.
26. Hasan S, Hosseini G, Princivalle M, Dong JC, Birsan D, Cagide C, de Agostini AI. Coordinate expression of anticoagulant heparan sulfate proteoglycans and serine protease inhibitors in the rat ovary : a potent system of proteolysis control. Biol Reprod 2002;66:144-58.
27. Dvorak HF, Nagy JA, Feng D, Brown LF, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. Curr Top Microbiol Immunol 1999;237:97-132.
28. Liu K, Brandstrom A, Liu YX, Ny T, Selstam G. Coordinated expression of tissue-type plasminogen activator and plasminogen activator inhibitor type 1 during corpus luteum formation and luteolysis in the adult pseudopregnant rat. Endocrinology 1996;137:2126-32.
29. Peng XR, Hsueh AJ, Ny T. Transient and cell-specific expression of tissue-type plasminogen activator and plasminogen-activator-inhibitor type 1 results in controlled and directed proteolysis during gonadotropin-induced ovulation. Eur J Biochem 1993;214:147-56.
30. Hagglund AC, Ny A, Liu K, Ny T. Coordinated and cell-specific induction of both physiological plasminogen activators creates functionally redundant mechanisms for plasmin formation during ovulation. Endocr 1996;137:5671-7.
31. Vassalli JD, Huarte J, Bosco D, Sappino AP, Sappino N, Velardi A, et al. Protease-nexin I as an androgen-dependent secretory product of the murine seminal vesicle. EMBO J 1993;12: 1871-8.
32. Carrell RW, Evans DLI. Serpins: mobile conformations in a family of proteinase inhibitors. Curr Opin Struct Biol 1992; 2:438-46.
33. Evans DL, McGrogan M, Scott RW, Carrell RW. Protease specificity and heparin binding and activation of recombinant protease nexin I. J Biol Chem 1991;266:22307-12.
34. Ehrlich HJ, KeijerJ, Preissner KT, Gebbink RK, Pannekoek H. Functional interaction of plasminogen activator inhibitor type 1 (PAI-1) and heparin. Biochem 1991;30:1021-8.
35. Rovelli G, Stone SR, Guidolin A, Sommer J, Monard D. Characterization of the Heparin-Binding Site of Glia-Derived Nexin/Protease Nexin-1. Biochem 1992;31:3542-9.
36. Wallace A, Rovelli G, Hofsteenge J, Stone SR. Effect of heparin on the glia-derived-nexin-thrombin interaction. Biochem J 1989;257:191-6.
37. Gebbink RK, Reynolds CH, Tollefsen DM, Mertens K, Pannekoek H. Specific glycosaminoglycans support the inhibition of thrombin by plasminogen activator inhibitor 1. Biochem 1993;32:1675-80.
38. Gettins PG, Fan B, Crews BC, Turko IV, Olson ST, Streusand VJ. Transmission of conformational change from the heparin binding site to the reactive center of antithrombin. Biochem 1993;32:8385-9.
39. Bronson FH, Dagg CP, Snell GD. Reproduction. In: Green EL, Coleman DL, Fahey EU (eds.), Biology of the laboratory mouse., 2 ed. New York: McGraw Hill; 1966: 187-200.
40. HajMohammadi S, Enjoyji K, Princivalle M, Christi P, Lech M, Beeler D, et al. Normal levels of anticoagulant heparan sulfate are not essential for normal hemostasis. J Clin Invest 2003; 111:989-99.
41. Cross JC, Baczyk D, Dobric N, Hemberger M, Hughes M, Simmons DG, Yamamoto H, Kingdom JCP. Genes, Development and Evolution of the Placenta. Placenta 2003;24:123-30.
42. Cross JC, Hemberger M, Lu Y, Nozaki T, Whiteley K, Masutani M, Adamson SL. Trophoblast functions, angiogenesis and remodeling of the maternal vasculature in the placenta. Mol Cell Endocrinol 2002;187:207-12.
43. Dong JC. Biology of anticoagulant heparan sulfate proteoglycans in reproduction. Geneva University, Sciences Faculty; 2002. Ph.D. Thesis in Biology.
44. Coetsier T, Dhont M. Complete and partial luteinized unruptured follicle syndrome after ovarian stimulation with clomiphene citrate/human menopausal gonadotrophin/human chorionic gonadotrophin. Hum Reprod 1996;11:583-7.
45. Bateman BG, Kolp LA, Nunley WC, Thomas TS, Mills SE. Oocyte retention after follicle luteinization. Fertil Steril 1990; 54:793-8.
46. Yildiz BO, Haznedaroglu IC, Kirazli S, Bayraktar M. Global fibrinolytic capacity is decreased in polycystic ovary syndrome, suggesting a prothrombotic state. J Clin Endocrinol Metab 2002;87:3871-5.
47. Ratts VS, Tao XJ, Webster CB, Swanson PE, Smith SD, Brownbill P, et al. Expression of BCL-2, BAX and BAK in the trophoblast layer of the term human placenta: a unique model of apoptosis within a syncytium. Placenta 2000;21:361-6.
48. Toki T, Horiuchi A, Ichikawa N, Mori A, Nikaido T, Fujii S. Inverse relationship between apoptosis and Bcl-2 expression in syncytiotrophoblast and fibrin-type fibrinoid in early gestation. Mol Hum Reprod 1999;5:246-51.
49. Sanson BJ, Friederich PW, Simioni P, Zanardi S, Huisman MV, Girolami A, et al. The risk of abortion and stillbirth in antithrombin-, Protein C, and Protein S-deficient women. Thromb Haemost 1996;75:387-8.
50. Gammaro L, Lippi G, Bottini E, Valenti G, Manzato F, Tessitore N, Maschio G. Severe preeclampsia in antithrombin III deficiency with no history of venous thromboembolism. J Nephrol 2001;14:312-5.
51. Walker ID. Thrombophilia in pregnancy. J Clin Pathol 2000; 53:573-80.
52. Kupfermine MJ, Eldor A, Steinman N, Many A, Bar-Am A, Jaffa A, et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 1999;340:9-13.
53. Kimya Y, Akdis C, Cengiz C, Ozan H, Tatlikazan S, Uncu G, Sengul F. Plasma interleukin-1 alpha, interleukin-1beta and interleukin-1 receptor antagonist levels in pre-eclampsia. Eur J Obstet Gynecol Reprod Biol 1997;73:17-21.
54. Haimov-Kochman R, Friedmann Y, Prus D, Goldman-Wohl DS, Greenfield C, Anteby EY, et al. Localization of heparanase in normal and pathological human placenta. Mol Hum Reprod 2002;8:566-73.
55. Bartocci A, Pollard JW, Stanley ER. Regulation of colony-stimulating factor 1 during pregnancy. J Exp Med 1986;164:956-61.
56. Hayashi M, Numaguchi M, Watabe H, Yaoi Y. High blood levels of macrophage colony-stimulating factor in preeclampsia. Blood 1996;88:4426-8.
57. Gotte M. Syndecans in inflammation. FASEB J 2003;17: 575-91.
58. Hoogewerf AJ, Kuschert GS, Proudfoot AE, Borlat F, Clark-Lewis I, Power CA, et al. Glycosaminoglycans mediate cell surface oligomerization of chemokines. Biochem 1997;36: 13570-8.
59. Coughlin SR. How the protease thrombin talks to cells. Proc Natl Acad Sci U S A 1999;96:11023-7.
60. Griffin CT, Srinivasan Y, Zheng YW, Huang W, Coughlin SR. A role for thrombin receptor signaling in endothelial cells during embryonic development. Science 2001;293:1666-70.
61. Hollenberg MD, Houle S. Proteinases as hormone-like signal messengers. Swiss Med Wkly 2005;135:425-32.